RADNOR, Pa.–(BUSINESS WIRE)–$MRNS #MarinusPharma—Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced the appointment of Marvin H. Johnson, Jr. to its Board of Directors. “With over 34 years of diverse commercial operations experience at Merck & Co., we are delighted that Marvin is … [Read more…]
COSTA MESA, Calif.–(BUSINESS WIRE)–Audax Private Equity (“Audax”), a leading alternative investment manager and capital partner, announced today that it has made a growth investment in Pyramid Laboratories, Inc. (“Pyramid” or the “Company”) to support the continued growth of the Company’s clinical and commercial biologics and advanced therapeutics manufacturing and service operations. Founded in 1988 by … [Read more…]
NEW YORK–(BUSINESS WIRE)–Ziff Davis, Inc. (NASDAQ: ZD) will release its First Quarter 2023 Earnings at 6:00PM ET on Tuesday, May 9, 2023. Additionally, Ziff Davis invites the public, members of the press, the financial community, stockholders, and other interested parties to listen to a live audio Webcast of its First Quarter 2023 Earnings Call at … [Read more…]
Study of 41 patients between ages 20 and 82 scored high on all five patient satisfaction metrics – including three perfect scores NEWPORT BEACH, Calif.–(BUSINESS WIRE)–Prospective Blinded Evaluation of Ur24 Technology’s revolutionary active external catheter system found it to be “highly effective” at removing urine from the bladder without tissue injury while scoring high patient … [Read more…]
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to live better, today announced its exclusive ONE by ONE and Biotrue® Eye Care Recycling programs have recycled a total of 65.8 million units, or 397,194 pounds, of used contact lenses, eye … [Read more…]
Alzheimer’s Disease (AD) Patients with APOE4/4 Homozygous Genotype Show More Frequent Cerebral Amyloid Angiopathy (CAA) Lesions at Baseline CAA Pathology Increases Risk of Treatment-Induced Brain Edema and Hemorrhage with Anti-Amyloid Antibodies in AD Patients with APOE4 Genotype Safety Profile in ALZ-801 Studies Remains Favorable & Consistent with Prior Data in Over 2,800 AD Patients, with … [Read more…]
Results from the EXPEDITE study of Remodulin® induction prior to Orenitram® therapy to be presented at ATS Baseline patient data from the TETON studies of Tyvaso® Inhalation Solution in patients with idiopathic pulmonary fibrosis to be presented at ATS ATS presentation examines geographical barriers as a social determinant of health for PAH patients; demonstrates UT’s … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “China Small Molecule CDMO Market Size, Share & Trends Analysis Report By Product (Active Pharmaceutical Ingredients API, Finished Drug Products), By Synthesis, By Drug, By Workflow, And Segment Forecasts, 2023 – 2030” report has been added to ResearchAndMarkets.com’s offering. The China small molecule CDMO market is expected to reach USD 46.0 billion by … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Hydrotherapy Equipment Market, By Type, By Application, By End Use, and by Region – Global Forecast to 2023-2033” report has been added to ResearchAndMarkets.com’s offering. The global hydrotherapy equipment market size was USD 3,452.4 million in 2022 and is expected to reach at USD 5,514.9 million by 2033 with a CAGR of 4.35% … [Read more…]
LONDON–(BUSINESS WIRE)–#biotech–MMS Holdings, a data-focused contract research organization (CRO), has been named a Great Place to Work-Certified™ organization in the UK. This comes as the number of MMS colleagues based in the UK has doubled in just one year. “We are proud to be certified as a Great Place to Work in the UK,” said … [Read more…]
